| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.364 | 16.749 | 14.951 | 18.265 | 19.469 | 13.006 | 31.717 | 36.308 | 36.109 |
| Total Income - EUR | - | 12.364 | 16.749 | 14.951 | 18.265 | 19.469 | 13.006 | 31.717 | 36.308 | 36.109 |
| Total Expenses - EUR | - | 1.845 | 2.939 | 1.977 | 2.743 | 1.892 | 2.131 | 1.711 | 9.997 | 10.407 |
| Gross Profit/Loss - EUR | - | 10.519 | 13.811 | 12.975 | 15.522 | 17.577 | 10.875 | 30.006 | 26.311 | 25.701 |
| Net Profit/Loss - EUR | - | 10.147 | 13.308 | 12.526 | 14.974 | 17.024 | 10.485 | 29.242 | 25.955 | 24.640 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cheregi Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 11.172 | 13.525 | 27.741 | 41.022 | 56.819 | 45.778 | 30.973 | 27.255 | 27.899 |
| Inventories | - | 0 | 95 | 94 | 92 | 90 | 88 | 88 | 88 | 88 |
| Receivables | - | 919 | 1.469 | 1.499 | 3.188 | 2.425 | 4.238 | 19.395 | 20.216 | 25.908 |
| Cash | - | 10.252 | 11.960 | 26.148 | 37.742 | 54.304 | 41.451 | 11.490 | 6.950 | 1.904 |
| Shareholders Funds | - | 10.192 | 13.352 | 25.633 | 40.110 | 56.374 | 45.394 | 29.283 | 25.996 | 24.688 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 980 | 173 | 2.109 | 911 | 445 | 384 | 1.691 | 1.259 | 3.211 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cheregi Med S.r.l.